Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Filing	Type	Shares Traded	Price	Total Held
May 22, 2015	GOLDSTEIN JOSEPH L Director Trans History: 381	Director	Form 4	Open market or private sale of non-derivative or derivative security	2,000	$514.81	20,000
May 27, 2015	SING GEORGE L Director Trans History: 326	Director	Form 4	Open market or private sale of non-derivative or derivative security	5,000	$515.00	112,772
May 22, 2015	McCorkle Douglas S VP Controller and Asst Treasur Trans History: 372	VP Controller and Asst Treasur	Form 4	Open market or private sale of non-derivative or derivative security	13,000	$515.60	4,481
Dec 01, 2020	RYAN ARTHUR F Director Trans History: 547	Director	Form 4	Open market or private sale of non-derivative or derivative security	2	$515.64	23,741
Apr 15, 2020	LAROSA JOSEPH J EVP General Counsel and Secret Trans History: 181	EVP General Counsel and Secret	Form 4	Open market or private sale of non-derivative or derivative security	414	$515.70	16,194
Dec 01, 2020	RYAN ARTHUR F Director Trans History: 547	Director	Form 4	Open market or private sale of non-derivative or derivative security	4	$516.37	23,737
May 22, 2015	INGRAM ROBERT ALEXANDER Director Trans History: 6	Director	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	3,788	$516.48	2,879
May 22, 2015	Van Plew Daniel P SVP & General Mgr Industrial O Trans History: 359	SVP & General Mgr Industrial O	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	1,556	$516.48	24,694
May 22, 2015	Van Plew Daniel P SVP & General Mgr Industrial O Trans History: 359	SVP & General Mgr Industrial O	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	12,734	$516.48	11,960
May 22, 2015	Van Plew Daniel P SVP & General Mgr Industrial O Trans History: 359	SVP & General Mgr Industrial O	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	567	$516.48	25,193

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media